P1533: TRIAL IN PROGRESS: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 3 STUDY OF THE EFFICACY AND SAFETY OF PARSACLISIB IN PATIENTS WITH PRIMARY WARM AUTOIMMUNE HEMOLYTIC...

por Barcellini, W., Butler, K., Moran, S., Bibeau, K., Dzhindzhikhashvili, I., Wei, S., Jäger, U.
Publicado 2022

Somatostatin-receptor scintigraphy for staging and follow-up of patients with extraintestinal marginal zone B-cell lymphoma of the mucosa associated lymphoid tissue (MALT)-type

por Raderer, M, Traub, T, Formanek, M, Virgolini, I, Österreicher, C, Fiebiger, W, Penz, M, Jäger, U, Pont, J, Chott, A, Kurtaran, A
Publicado 2001

Alemtuzumab-BEAM as conditioning for allogeneic hematopoietic stem cell transplantation in relapsed/refractory Hodgkin lymphoma: a single-center analysis

por Rabitsch, W., Bojic, M., Wohlfarth, P., Leiner, M., Schörgenhofer, C., Kalhs, P., Schulenburg, A., Sillaber, C., Mitterbauer, M., Sperr, W. R., Jäger, U., Skrabs, K., Greinix, H., Hermann, A., Lamm, W.
Publicado 2016

PB2115: TRIAL IN PROGRESS: A RANDOMIZED PHASE II STUDY OF MB-CART2019.1 COMPARED TO STANDARD OF CARE THERAPY IN PATIENTS WITH RELAPSED/REFRACTORY DLBCL INELIGIBLE FOR AUTOLOGOUS ST...

por Borchmann, P., Vandenberghe, P., Urbano, A., Haioun, C., Lemonnier, F., Griškevicius, L., Maury, S., Holtkamp, S., Friedrichs, B., Zadoyan, G., Hanssens, L., Brillant, C., Bethke, U., Assenmacher, M., Bürger, I., Philippe, B., Overstijns, T., Jäger, U., Kersten, M. J.
Publicado 2022